THE ROLE OF SUPPRESSOR CELLS IN THE DEVELOPMENT OF ALLERGIC DISEASES
Keywords:
allergy, immunopathogenesis, Th2 cells, Treg regulatory cells, cellular immunotherapy.Abstract
Allergic diseases occupy one of the leading positions in human pathology. Hundreds of millions of people in the world suffer from bronchial asthma, urticaria, atopic dermatitis and other forms of allergic pathology. The main indicator of the immunopathogenesis of allergic diseases is the increased activity of the Th-2 cell population. Against the background of reduced Th-1 activity involving cells such as eosinophils, mast cells, etc. in the pathogenesis of the disease, against the background of increased synthesis of immunoglobulin E. The immunopathogenesis of allergic diseases is based on the reduced activity of regulatory cells of various populations.
References
Gagliani N., Magnani C.F., Huber S., Gionolini M.E., Pala M., Licona-Limon P. et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 2013; 19(6): 739—46.
Rivas M.N., Chatila T.A. Regulatory T cells in allergic diseases. J. Allergy Clin. Immunol. 2016: 138(3): 639—51.
Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J.Allergy Clin. Immunol. 2014; 133(3): 621—31.
Thunberg S., Akdis M., Akdis C.A., Gronneberg R., Malmstrom V., Trollmo C. et al. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls. Clin. Exp. Allergy. 2007; 37(8): 1127—30.
Grindebacke H., Wing K., Andersson A.C., Suri-Payer E., Rak S., Rudin A. Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy. 2004; 34(9): 1364—72.
Kanamoori M., Nakatsukasa H., Okada M., Lu Q., Yoshimura A. Induced regulatory T cells: their development, stability, and applications. Trends Immunol. 2016; 37(11): 803—11.
Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A. et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)Len and Allergen). Allergy. 2008; 63(86): 8—160.
McGee H.S., Agrawal D.K. Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma. Am. J. Respir. Crit. Care Med. 2009; 180(3): 211—25.
Dorsey N.J., Chapoval S.P., Smith E.P., Skupsky J., Scott D.W., Keegan A.D. STAT6 controls the number of regulatory T cells in vivo thereby regulating allergic lung inflammation. J. Immunol. 2013; 191(4): 1517— 28.
Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A. et al. Il-4 inhibits TGF-beta-induced Foxp3 T cells and together with TGF-β generates IL-9+IL-10 Foxp3-effector T cells. Nat. Immunol. 2008; 9(12): 1347—55.
